Celazome Cream
NDC 58466-901
Product Information
Celazome (oxybenzone, octinoxate, octisalate, and homosalate) is a OTC MONOGRAPH DRUG-approved product labeled by Dermazone Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a cream for topical administration. This product entry covers the primary NDC 58466-901 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 58466-901?
What are the uses of this product?
What are Active Ingredients of this product?
- HOMOSALATE 50 mg/g - cpd not photoallergenic
- OCTINOXATE 75 mg/g
- OCTISALATE 50 mg/g
- OXYBENZONE 50 mg/g
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- OXYBENZONE (UNII: 95OOS7VE0Y)
- OXYBENZONE (UNII: 95OOS7VE0Y) (Active Moiety)
- OCTINOXATE (UNII: 4Y5P7MUD51)
- OCTINOXATE (UNII: 4Y5P7MUD51) (Active Moiety)
- OCTISALATE (UNII: 4X49Y0596W)
- OCTISALATE (UNII: 4X49Y0596W) (Active Moiety)
- HOMOSALATE (UNII: V06SV4M95S)
- HOMOSALATE (UNII: V06SV4M95S) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- DIOCTYL MALEATE (UNII: OD88G8439L)
- ALCOHOL (UNII: 3K9958V90M)
- SORBITOL (UNII: 506T60A25R)
- DIETHANOLAMINE CETYL PHOSPHATE (UNII: 4UG0316V9S)
- ALOE VERA LEAF (UNII: ZY81Z83H0X)
- .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- TROLAMINE (UNII: 9O3K93S3TK)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- METHYLPARABEN (UNII: A2I8C7HI9T)
* Please review the full disclaimer at the bottom of this page.